Sermorelin Sermorelin, the synthetic version of naturally occurring growth hormone-releasing hormone (GHRH), has been gaining some attention as an alternative to weight loss injectables like Mounjaro and Wegovy
Individual variations in GLP-1 receptor sensitivity, baseline gastric motility, and genetic factors may also influence susceptibility to these adverse effects
GLP-1-deficient mice demonstrate decreased liver glycogen accumulation downstream of AKT and glycogen synthase a signaling [85]
To learn how peptides fit into a broader wellness plan, explore ThinWorks' Peptide Therapy options
Over the next several years, as more innovative therapies enter clinical development and commercialization, the GLP-1 field is expected to maintain rapid growth while expanding into broader metabolic disease management
It primarily affects growth hormone without substantially elevating cortisol, prolactin, or ACTH levels